- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 10, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The CER Daily Newsfeed, a newsletter from the National Pharmaceutical Council (NPC), cited a story on AJMC.com, the website of The American Journal of Managed Care® (AJMC®), about the Federal Trade Commission opening up an investigation into the business practices of the 6 largest pharmacy benefit managers. The story, "In Reversal, FTC Launches Inquiry Into PBM Industry," included interviews with the CEOs of the NPC as well as the Pontchartrain Cancer Center.
A piece by AJMC®'s sister site, Pharmacy Times®, cited a supplemental study published in AJMC®. The study, “Health Outcomes From an Innovative Enhanced Medication Therapy Management Model,” found that medication safety reviews were effective at improving annual health care costs, hospitalizations, emergency department visits, and mortality in Medicare beneficiaries targeted according to MedWise Risk Score.
Venetoclax May Be an Option for Children With R/R AML, MDS
November 27th 2024The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with relapsed or refractory (R/R) acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Read More
Expert Insights on How Utilization Management Drives Physician Burnout
November 26th 2024On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The American Journal of Managed Care® to explore the link between utilization management and physician burnout.
Listen
